Damora Therapeutics Inc (DMRA)

Finanzdaten der Damora Therapeutics Inc-Aktie (DMRA)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	13.58%34.99	30.81	201.70	3.16	3.42
Research and Development	7.41%25.54	23.78	23.32	1.42	1.47
Operating Income/Loss	13.58%-34.99	-30.81	-201.70	-3.16	-3.42
Net Interest Income/Expense	32.21%4.06	3.07	1.00	0.04	0.05
Nonoperating Income/Loss	32.74%4.08	3.07	1.00	0.02	-0.01
Income/Loss From Continuing Operations Before Tax	11.46%-30.92	-27.74	-200.69	-3.13	-3.43
Income Tax Expense/Benefit	507.14%0.26	0.04	0.04	-	0.00
	12.30%-31.20	-27.78	-200.74	-3.10	-3.40
Attributable To Parent	12.21%-31.17	-27.78	-200.74	-3.13	-3.44
Basic Average Shares	78.19%61.12	34.30	-	1.33	1.32
Diluted Average Shares	78.19%61.12	34.30	-	1.33	1.32
Basic Earnings Per Share	37.10%-0.39	-0.62	-	-2.36	-2.60
Diluted Earnings Per Share	37.10%-0.39	-0.62	-	-2.36	-2.60
Common Stock Dividends	-	-	-	-	-